Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
- Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
- Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
- Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)
- Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
- Tocilizumab Treatment in Patients With COVID-19
- Autologous Transplant To End NMO Spectrum Disorder
- Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia
- Omental Islet Transplant
- Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation
- Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
- An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
- Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
- Role of Everolimus in Highly Sensitized Patients
- Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
- Intravenous Gammaglobulin for Sickle Cell Pain Crises
- Long-Term Study of IGIV, 10% in Alzheimer´s Disease
- A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients
- Multi-Drug Desensitization Protocol for Heart Transplant Candidates
- Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
- Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy
- Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants
- Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
- Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
- Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
- Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation
- Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
- Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC
- IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load
- Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
- A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
- Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
- Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) Subjects
- MMF vs. AZA for Kidney Transplantation
- A Clinical Study of Intravenous Immunoglobulin
- Preventive IVIG Therapy for Congenital Heart Block
- Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
- A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.
- Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis
- Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
- Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
- Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
- Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
- Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
- Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
- Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
- Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer
- Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
- Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
- Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
- Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
- Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation
- Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
- Evaluation and Treatment of Eye Complications of Vaccinia Vaccination
- Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
- Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever
- Prevention of Recurrent Hepatitis B After Liver Transplantation
- Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
- Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
- Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
- Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
- Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
Clinical trials list
click for details